NCT05397236View on ClinicalTrials.gov

Addition of MgSO4 or Dexamethasone to Bupivacaine on the Prolongation of Ultrasound-guided Quadratus Lumboram Block

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Post Operative Pain
Interventions
DRUG

Bupivacaine- Magnesium

Patients received QL block with 20 ml of 0.25% bupivacaine (2, 4)plus 5 ml of 10% MgSO4.

DRUG

Bupivacaine dexamethasone

Patients received QL block with 20 ml of 0.25% bupivacaine (2,4)plus 2 ml of 8 mg dexamethasone plus 3 ml of 0.9% NS.

DRUG

Bupivacaine saline

Patients received QL block with 20 ml of 0.25% bupivacaine (2,4)plus 5 ml of 0.9% NS.

Trial Locations (1)

Unknown

Ain-Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER